Lilly to Provide Detailed Update of Pipeline and R&D Strategy at Upcoming Investment Community Meeting

News provided by

Apr 12, 2016, 10:00 ET

INDIANAPOLIS, April 12, 2016 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced it will host a meeting for the investment community, including institutional investors, sell-side analysts, ratings agency representatives, and financial and business media.

The meeting will take place Tuesday, May 24, 2016, from 10:00 a.m. (EDT) until approximately 3:00 p.m., in New York City.

The investment community meeting will focus on Lilly's research and development opportunities in diabetes, immunology, oncology and pain. It follows a similar meeting in December 2015 to review the company's broad Alzheimer's disease pipeline. The presentations will include discussion of new indications and line extensions for a number of established products as well as late-stage and select earlier-stage new molecular entities. There will be Q&A opportunities throughout the meeting.

A live webcast of the Lilly investment community meeting, along with presentation slides, will be available through a link on the investor section of Lilly's website at https://investor.lilly.com/events.cfm. An audio replay will also be available for approximately one month.

Because of limited space, advance registration is required. Media interested in attending in person should contact Molly McCully at (317) 478-5423. Investors interested in attending should contact Edward Villacorta at (317) 433-1805.

About Eli Lilly and Company
Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and newsroom.lilly.com/social-channels. F-LLY

Refer to: Molly McCully; [email protected]; 317-478-5423 (Media)
Philip Johnson; [email protected]; 317-655-6874 (Investors)

Logo - http://photos.prnewswire.com/prnh/20031219/LLYLOGO

SOURCE Eli Lilly and Company